Purchase Order W81K0018P0044
Award Date
11/21/17
Potential Completion Date
9/30/22
Potential Value
$1.5M
Federal Agency
Medical Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $244,758.17, was issued by the Defense Health Agency to Immucor Inc., a manufacturer of goods, for the delivery of CAP R RS (3) 5 PLATE DOMESTIC. The contract is a firm fixed-price purchase order without a set-aside designation, with a period of performance through May 31, 2024. Immucor is a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The company has a history...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The contract, valued at $535,165.00, is for the delivery of two blood bank automated analyzers to support the Pathology Department at William Beaumont Army Medical Center at Fort Bliss, Texas. The contract term is from October 1, 2023,...
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This federal contract was awarded by the Department of Health and Human Services Indian Health Service to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The $114,896.73 firm fixed-price purchase order is for a "BLOOD SYSTEM AND SUPPORT SERVICE" to be performed in Phoenix, Arizona. The contract has a completion date of September 30, 2023 and was originally awarded on August 29,...
This contract award is to Immucor Inc., a leading provider of automated instruments, reagents, and consumables for blood transfusion and transplantation compatibility testing. The award, valued at $6,462.79, is a firm fixed-price purchase order placed by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. Immucor has previously provided a variety of goods and services related to in vitro diagnostics, reagents, test kits,...
This is a delivery order contract awarded to Immucor Inc. by the Department of the Army Medical Command for the provision of blood typing reagents. The contract has a potential value of $120,612.04 and a completion date of September 30, 2019. Immucor Inc. is a manufacturer of in vitro diagnostic products, reagents, and test kits for blood transfusion and transplantation compatibility testing. The contract was not set aside for any specific business category. Immucor has held previous federal...